Philip Reilly

Philip Reilly

Direttore/Membro del Consiglio presso
Cornell University
Health Technology
Consumer Services
Finance

Profilo

Phil focuses on creating and building companies that develop breakthrough therapies for orphan genetic diseases.
He is passionate about working with patient groups, and helping to unite those suffering from rare diseases in order to foster a support network and potentially improve patient outcomes.
Phil has authored or co-authored more than 100 articles in scholarly journals and has published seven books including most recently Orphan: The Quest to Save Children with Rare Genetic Disorders.
Phil currently serves on the Advisory Board to the Boston University School of Public Health, and has served as a trustee emeritus of Cornell University, an Overseer of Weill Cornell Medical College.

Posizioni attive di Philip Reilly

SocietàPosizioneInizio
Direttore/Membro del Consiglio 03/06/2010
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Philip Reilly

SocietàPosizioneFine
Direttore/Membro del Consiglio 31/12/2016
INTERLEUKIN GENETICS, INC Presidente -
VOYAGER THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S -
Fondatore -
GENETIX BIOTHERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Philip Reilly

Formazione di Philip Reilly

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

88

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Philip Reilly